OOIR: Observatory of International Research

Papers

(The H4-Index of World Psychiatry is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
WPA scientific publications in the triennium 2020‐2023	694
R. Spitzer and the depathologization of homosexuality: some considerations on the 50th anniversary	495
What is good acute psychiatric care (and how would you know)?	489
Trauma, coloniality and survivance among Indigenous peoples in the US	407
Advancing global mental health through education	351
Evidence‐informed is not enough: digital therapeutics also need to be evidence‐based	287
Detecting and managing non‐suicidal self‐damaging behaviors	281
Patterns and correlates of patient‐reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys	258
Beyond symptom improvement: transdiagnostic and disorder‐specific ways to assess functional and quality of life outcomes across mental disorders in adults	252
Therapist‐supported Internet‐based cognitive behaviour therapy yields similar effects as face‐to‐face therapy for psychiatric and somatic disorders: an updated systematic review and meta‐analysis	218
From inter‐brain connectivity to inter‐personal psychiatry	215
Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta‐analysis	203
	195
Prenatal exposure to antidepressants or antipsychotics and the risk of seizure in children	180
	179
Breaking down barriers to conversations about sexual and reproductive health	179
Mental health literacy for supporting children: the need for a new field of research and intervention	178
The “Meet the WPA Council” Panel at the 21st World Congress of Psychiatry	173
Achieving equality, inclusiveness, and cultural sensitivity in mental health (EDIT)	143
Sex differences need to be considered when treating women with psychotropic drugs	139
How common is secondary psychosis? Estimates from a systematic review and meta‐analysis	139
Burnout: a case for its formal inclusion in classification systems	135
Prevention, treatment and care of substance use disorders in times of COVID‐19	133
Scientific validation of the ICD‐11 CDDR	132
The aggregation of marginal gains: a pragmatic philosophy of clinical care in psychiatry	126

Alternatives to coercion in mental health care: WPA Position Statement and Call to Action	121
Functional neurological disorder: defying dualism	114
Designing and scaling up integrated youth mental health care	102
Potential for prediction of psychosis and bipolar disorder in Child and Adolescent Mental Health Services: a longitudinal register study of all people born in Finland in 1987	98
One world, one profession: psychiatry	96
Key considerations for clinical trials in psychopharmacology	94
How the ICD‐11 and the CDDR address the public health dimensions of substance use	87
After the acute crisis – engaging people with psychosis in rehabilitation‐oriented care	83
Augmenting trauma‐focused cognitive behavior therapy for post‐traumatic stress disorder with memory specificity training: a randomized controlled trial	82
The Hikikomori Diagnostic Evaluation (HiDE): a proposal for a structured assessment of pathological social withdrawal	78
A lived experience perspective on the new World Mental Health Report	76
Education, policy and clinical care in mental health: an update on the activities of WPA Collaborating Centres	75
The hypothesis of biologically based subtypes of schizophrenia: a 10‐year update	74
What makes Internet‐based interventions work?	73
Outcomes in people with eating disorders: a transdiagnostic and disorder‐specific systematic review, meta‐analysis and multivariable meta‐regression analysis	72
Ongoing phase 2/3 trials of psychotropic drugs: is help finally on the way?	71
Treatment of substance use disorders in prison settings: statement by the UNODC‐WHO Informal Scientific Network, UN Commission on Narcotic Drugs	69
WPA scientific meetings 2020‐2023	65
Management of generalized anxiety disorder and panic disorder in general health care settings: new WHO recommendations	60
Reflections on the current status of psychiatric epidemiology and public mental health	60
Promoting collaboration, harmonization and dissemination in depression research: the ECNP Depression Meta‐Network	57
Meeting the challenges of the new frontier of youth mental health care	55
Intimate partner violence and mental health: lessons from the COVID‐19 pandemic	52
COVID‐19 vaccination uptake in people with severe mental illness: a UK‐based cohort study	51